| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4931408 | Journal of the American Academy of Child & Adolescent Psychiatry | 2017 | 29 Pages |
Abstract
In AAP-treated Medicaid-insured youth, concomitant SSRI/SNRI use was associated with a heightened risk of T2DM, which intensified with increasing duration and dose.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Mehmet PhD, MS, Julie M. PhD, Daniel J. MD, Laurence S. PhD, Susan PhD, Fadia T. PhD, MPH, Geoffrey L. MD, PhD,